Abstract 3476: Mechanistic evaluation of VS-6766 (dual RAF/MEK inhibitor) and defactinib (FAK inhibitor) in low-grade serous ovarian cancer models with correlations to clinical response

Adam Stewart, Lisa Pickard, Ekta Paranjape, Victoria Perez, Sanjib Chowdhury, Stephanie Lustgarten, Silvia Coma, Jonathan Pachter, Mark Carey, Gabriel DiMattia, Hannah Badham, Toby Prout, Mona Parmar, Muneeb Mahmud, Christina Yap, Matthew Krebs, Susana Banerjee, Udai Banerji

Research output: Contribution to conferencePosterpeer-review

Fingerprint

Dive into the research topics of 'Abstract 3476: Mechanistic evaluation of VS-6766 (dual RAF/MEK inhibitor) and defactinib (FAK inhibitor) in low-grade serous ovarian cancer models with correlations to clinical response'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science